Showing 161 - 180 results of 14,940 for search '(( significant ((we decrease) OR (greatest decrease)) ) OR ( significant increase decrease ))', query time: 0.51s Refine Results
  1. 161
  2. 162
  3. 163

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  4. 164

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  5. 165
  6. 166
  7. 167
  8. 168

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  9. 169

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  10. 170

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  11. 171

    S1 Data - by Miki Doi (15347878)

    Published 2024
    Subjects:
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180